Publications by authors named "Tianfu Wen"

Claim this Profile
C
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition).
Jian Zhou, Huichuan Sun, Zheng Wang, Wenming Cong, Mengsu Zeng, Tianfu Wen, Wenwu Cheng, Wengzhi Guo, Wentao Wang

Liver Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PERI-START: a phase II trial of perioperative TACE, tislelizumab, and lenvatinib in early-stage hepatocellular carcinoma.
Diao Kong, Yongcheng Tang, Yongjie Zhou, Jin Zhou, Chuan Li, Tianfu Wen

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial.
Zheng Wang, Jia Fan, Shaolai Zhou, Yunfan Sun, Fei Liang, Tianfu Wen, Wenqing Zhu

Lancet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of immune checkpoint inhibitors in hepatocellular carcinoma: a comprehensive umbrella review of meta-analyses.
Ying Zhou, Ming-Hong Yao, Ji Ma, Tian-Fu Wen, Xiao-Yun Zhang

Int J Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low preoperative serum creatinine levels are associated with poor prognosis in patients with hepatocellular carcinoma after liver resection: a multicenter study.
Li Qin, Zhan-Cheng Qiu, Fei Xie, Yu Zhang, Yu Yu, Tian-Fu Wen

BMC Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion Resection or Direct Resection for Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicentre Study.
Ying Zhou, Haiqing Wang, Jiayi Wu, Junyi Shen, Ji Ma, Tianfu Wen

Liver Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Efficacy between Lenvatinib and Bevacizumab in Combination of Immune Checkpoint Inhibitor and Interventional Triple Therapy in Chinese Advanced Hepatocellular Carcinoma: The CLEAP 2302 Study.
Zhaolong Pan, Dongming Liu, Junbo Cao, Linlin Fu, Xihao Zhang, Tianfu Wen

Liver Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcome of Repeat Resection versus Radiofrequency Ablation for Intrahepatic Recurrence after Curative Resection of Hepatocellular Carcinoma Initially within Barcelona Clinic Liver Cancer Staging System 0-A Stages: A Multicenter Study.
Yueqing Xu, Xiaoyun Zhang, Haiqing Wang, Zonghan Liu, Jiayi Wu, Tianfu Wen

Dig Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic versus open hepatectomy in hepatocellular carcinoma patients with high-risk pathological features: a multicenter propensity score-matched study.
Li Qin, Ying Zhou, Zhan-Cheng Qiu, Ting-Hao Cheng, Yu Zhang, Tian-Fu Wen

Surg Endosc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapy.
Kong-Ying Lin, Hong-Zhi Liu, Jian-Wei Liu, Xiao-Dong Zhu, Yang-Xun Pan, Tian-Fu Wen

Eur J Surg Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy enhances triple therapy for conversion and survival in patients with unresectable hepatocellular carcinoma with portal vein tumor thrombus.
Ying Zhou, Minghong Yao, Tianfu Wen, Chuan Li

Biosci Trends· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prognostic score based on early recurrence-related factors for hepatocellular carcinoma patients with microvascular invasion after hepatectomy.
Hongyu Li, Junyi Shen, Tianfu Wen

Langenbecks Arch Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial.
Yinghong Shi, Guohong Han, Jian Zhou, Xuetao Shi, Weidong Jia, Tianfu Wen, Weiwen Su, Wenzhi Guo, Wenhua Zhang

Lancet Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraoperative Blood Transfusion has a Distinct Impact on the Long-Term Prognosis of Hepatocellular Carcinoma Patients With Different Alpha-Fetoprotein-Tumor Burden Scores After Liver Resection: A Large-Scale Multicenter Study.
Li Qin, Zhan-Cheng Qiu, Yu Zhang, Fei Xie, Yu Yu, Tian-Fu Wen

World J Surg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study.
Jin-Hong Chen, Lu Lu, Xiao-Yun Zhang, Bang-De Xiang, Xiao Xu, Tian-Fu Wen, Wen-Wei Zhu

Hepatobiliary Pancreat Dis Int· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021.
Hong Zhao, Yilei Mao, Hongguang Wang, Aiping Zhou, Zhengqiang Yang, Feng Wen, Tianfu Wen

Cancer Innov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).
Yu Yang, Juxian Sun, Jianqiang Cai, Minshan Chen, Chaoliu Dai, Tianfu Wen, Xuewen Zhang, Wenjing Wei

Liver Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study.
Hui-Chuan Sun, Zhi-Yong Huang, Tianfu Wen, Lianxin Liu, Xiao-Dong Zhu

J Hepatocell Carcinoma· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of short-term exercise-based prehabilitation program for patients undergoing liver cancer surgery: A randomized controlled trial.
Shiqi Liang, Linyan Yuan, Ao Wang, Siqin Li, Yonggang Wei, Tianfu Wen

Surgery· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir vs Entecavir on the Prognosis of Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Resection: The Role of HBsAg Levels.
Zhancheng Qiu, Yueqing Xu, Weili Qi, Junyi Shen, Tianfu Wen

Clin Transl Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of textbook outcomes between laparoscopic and open liver resection for patients with hepatocellular carcinoma: a multicenter study.
Si-Yuan Luo, Li Qin, Zhan-Cheng Qiu, Fei Xie, Yu Zhang, Tian-Fu Wen

Surg Endosc· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor burden score combined with AFP and PIVKA-II (TAP score) to predict the prognosis of hepatocellular carcinoma patients after radical liver resection.
Zhan-Cheng Qiu, You-Wei Wu, Jun-Long Dai, Wei-Li Qi, Chu-Wen Chen, Tian-Fu Wen

Langenbecks Arch Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).
Haowen Tang, Wenwen Zhang, Junning Cao, Yinbiao Cao, Xinyu Bi, Wenbing Sun, Wenbin Ji, Wenheng Zheng, Wentao Wang, Tianfu Wen

Biosci Trends· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomogram for predicting early cancer-related death due to recurrence after liver resection in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a multicenter study.
Zhan-Cheng Qiu, Hao-Zheng Cai, You-Wei Wu, Jun-Long Dai, Wei-Li Qi, Chu-Wen Chen, Tian-Fu Wen

BMC Gastroenterol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic assessment of early-stage liver cirrhosis induced by HCV using an integrated model of CX3CR1-associated immune infiltration genes.
Haozheng Cai, Jing Zhang, Chuwen Chen, Junyi Shen, Xiaoyun Zhang, Tianfu Wen

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis